Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

Veritone Inc (VERI.O)*

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date Stock Price (US$) Price Target (US$) Rating
2022-03-3018.85-No Rating
2022-04-1115.9618.00Neutral
2022-05-0310.8813.00Neutral
2022-08-107.949.00Neutral
2022-11-085.977.00Neutral
2023-01-318.459.00Neutral
2023-03-026.367.50Neutral
2023-05-024.265.00Neutral
2023-06-023.293.50Neutral
2023-10-252.293.00Neutral
2024-01-151.802.00Neutral
2024-03-203.96-No Rating
2024-10-293.703.50Neutral
2025-02-242.69-No Rating
2025-02-262.753.50Neutral
2025-05-091.812.00Neutral

Disclosures

  • Within the past 12 months, UBS has received compensation for investment banking services from this company/entity or one of its affiliates.
  • UBS Securities LLC makes a market in the securities and/or ADRs of this company.
  • Because this security exhibits higher-than-average volatility, the FSR has been set at 25% above the MRA for a Buy rating, and at -25% below the MRA for a Sell rating (compared with 6/-6% under the normal rating system).
  • UBS holds a long or short position of 0.5% or more of the listed shares of this company.
Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day. Issuers with an EQ Rating & Price Target Table are covered by UBS-IB Equity Research Analysts. Issuers without an EQ Rating & Price Target Table are not single stock covered.

* Issuers marked with an asterisk are covered by UBS-IB Equity Research Analysts. Issuers without an asterisk are not single stock covered.